Bookmark Email Print page

Our life sciences service offering

Life sciences

Life sciences service

Shrinking margins, evolving regulations, rising R&D costs: life sciences companies face a range of significant challenges for the years ahead.

To adapt effectively, pharmaceutical, medical device providers and biotechnology organisations must not only accelerate their development processes, they must also re-examine their underlying operational strategies:

  • Pharmaceutical organisations need to align their distribution channels and create new business models. Focus should be put on developing better cooperation with payers and regulators and on constantly adapting and maintaining key competencies
  • Biotechnology companies are facing increased competition, including the rise of “biogenerics “. They should focus on developing a powerful R&D cycle and need to finance investments over the whole development life-cycle
  • For medical devices companies, technological innovations remain the main success driver for developing products responding to the needs of an aging population. In addition, they are more and more impacted by regulatory constraints

The depth of our global and local expertise in the area of life sciences and health care enables us to provide our clients with general as well as specific insights and forecasts of their environments. Our multidisciplinary functional practice, notably in the area of consulting (strategy, operations, information technology, human capital, financial services, risk management…), seeks to provide the different stakeholders operating in the life sciences sphere with made-to-measure support to meet the challenges they face.

We summarise in the following pages in a generic manner some of the main challenges in which we have assisted our clients over the past years. We then describe our most pertinent service offerings to address those challenges.

Contact

  • Gilbert Renel
    Health sciences Partner

Learn more

  • Biotech CEO report: key issues
    Stingy capital markets make for turbulent times
Stay connected:
Get connected
Share your comments
More on Deloitte Luxembourg
Learn about our site

Recently blogged